Advertisement
U.S. Markets close in 4 hrs 12 mins

Aldeyra Therapeutics, Inc. (ALDX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
5.41+0.01 (+0.19%)
As of 11:46AM EST. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
43,050
42,794
62,680
56,220
34,667
Operating Income
-43,050
-42,794
-62,680
-56,220
-34,667
Net Non Operating Interest Income Expense
5,180
5,252
655.351
-1,557
-1,612
Other Income Expense
-
-
-
-
-1,754
Pretax Income
-37,870
-37,543
-62,025
-57,776
-38,033
Tax Provision
-
-
-
0
-479.265
Net Income Common Stockholders
-37,870
-37,543
-62,025
-57,776
-37,554
Diluted NI Available to Com Stockholders
-37,870
-37,543
-62,025
-57,776
-37,554
Basic EPS
-0.78
-0.64
-1.06
-1.07
-1.11
Diluted EPS
-0.78
-0.64
-1.06
-1.07
-1.11
Basic Average Shares
58,785
58,943
58,406
54,042
33,966
Diluted Average Shares
58,785
58,943
58,406
54,042
33,966
Total Operating Income as Reported
-43,050
-42,794
-62,680
-56,220
-36,421
Total Expenses
43,050
42,794
62,680
56,220
34,667
Net Income from Continuing & Discontinued Operation
-37,870
-37,543
-62,025
-57,776
-37,554
Normalized Income
-37,870
-37,543
-62,025
-57,776
-35,822
Interest Income
7,209
7,323
2,349
185.363
292.224
Interest Expense
2,029
2,071
1,694
1,742
1,904
Net Interest Income
5,180
5,252
655.351
-1,557
-1,612
EBIT
-35,840
-35,471
-60,331
-56,034
-36,129
EBITDA
-35,587
-35,208
-60,072
-55,770
-36,073
Reconciled Depreciation
253.731
262.78
258.707
264.18
56.221
Net Income from Continuing Operation Net Minority Interest
-37,870
-37,543
-62,025
-57,776
-37,554
Total Unusual Items Excluding Goodwill
-
-
-
0
-1,754
Total Unusual Items
-
-
-
0
-1,754
Normalized EBITDA
-35,587
-35,208
-60,072
-55,770
-34,318
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-22.4546